Cross-cultural adaptation and validation for central sensitization inventory: based on Chinese patients undergoing total knee arthroplasty for knee osteoarthritis Authors: Chao Xu, Shuxin Yao, Wei Wei, Haiyue Zhang, Jianbing Ma, Lei Shang Published: 2023 ABSTRACT BackgroundThis study was conducted to develop a simplified Chinese version of the central sensitization inventory (CSI-CV) and to evaluate its reliability and validity.MethodsThe CSI-CV was developed through a process involving the translation and back translation of the original CSI. Subsequently, experts reviewed and revised the content of the items to ensure their appropriateness. A total of 325 patients with knee osteoarthritis (KOA), who were scheduled to undergo total knee arthroplasty (TKA), completed the CSI-CV at a prominent orthopedic center in Xi'an, China. Afterward, a random selection of 100 participants was chosen for retesting after one week. The reliability and validity of the inventory were evaluated through exploratory factor analysis, correlation coefficient calculation and other methods.ResultsThe CSI-CV consists of 25 items in five dimensions (emotional distress, headache and jaw symptoms, physical symptoms, urological symptoms, and fatigue and sleep problems). The cumulative variance contribution rate was 75.3%, the Cronbach's α coefficient was 0.83, the Guttman split-half reliability coefficient was 0.88 and the intraclass correlation coefficient was 0.965. The CSI-CV scores correlated moderately with the total scores of the brief pain inventory (r = 0.506), Western Ontario and McMaster Universities Osteoarthritis Index (r = 0.466) and EuroQoL Group's five-dimension questionnaire (r = 0.576).ConclusionsThe findings demonstrate that the CSI was successfully trans-culturally adapted into a simplified Chinese version (CSI-CV) that was reliable and valid for Chinese-speaking patients who awaiting TKA for KOA.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13018-023-04375-3. Background Knee osteoarthritis (KOA) is one of the most common degenerative diseases in elderly populations, resulting in chronic persistent pain and functional disability [1]. The average crude prevalence of KOA among individuals aged over 55 years was 13.2% between the years 2008 and 2017 in China [2]. Despite the recognized effectiveness of total knee arthroplasty (TKA) as a surgical intervention for end-stage KOA, a notable percentage (approximately 10–20%) of patients still report dissatisfaction [3]. Persistent unexplained pain following TKA has emerged as one of the strongest factors associated with this dissatisfaction [4]. Over the past few decades, the concept of central sensitization (CS) has been developed. It is defined as an enhanced responsiveness of nociceptive neurons in the central nervous system to their normal or subthreshold afferent input [5]. CS has been recognized as a significant risk factor for persistent pain and patient dissatisfaction after TKA [6–12]. Therefore, assessing the patient's CS status before surgery is essential to enable early intervention if necessary [13]. Several attempts have been made to objectively quantify CS, such as Quantitative Sensory Testing (QST) [14, 15] and (f)MRI [16, 17]. While these tools can provide valuable information, they are often complex, time-consuming, and expensive [18]. To address these limitations, researchers are investigating the feasibility of utilizing more accessible and cost-effective methods, such as the central sensitization inventory (CSI). CSI is a self-report questionnaire, which identifies key symptoms associated with CS and quantifies the severity of these symptoms [19]. The questionnaire consists of two parts, Part A assesses 25 CS-related symptoms regarding the patient’s current conditions, while Part B investigates whether the patient has or had 10 central sensitivity syndromes (CSS) (fibromyalgia, chronic fatigue syndrome, temporomandibular joint disorder, irritable bowel syndrome, migraine or tension headaches, multiple chemical sensitivities, and restless leg syndrome, neck injuries, anxiety or panic attacks, depression) [19]. The CSI has been translated and validated in multiple countries for patients with chronic pain resulting from various causes [19–32]. Previously, Feng et al. translated and validated the traditional Chinese version of the CSI in Hong Kong [23]. Traditional Chinese is written and spoken in regions like Hong Kong, Macau, Taiwan, and Singapore. Simplified Chinese is the predominant official language in mainland China. This linguistic diversity reflects the cultural and geographical variations [33]. The majority of individuals in mainland China may encounter difficulties when it comes to reading and writing in traditional Chinese [33, 34]. Consequently, there is a pressing need to translate and culturally adapt the simplified Chinese version of the CSI. As such, the objective of this study is to translate, cross-culturally adapt, and validate the psychometric properties of the CSI in mainland Chinese KOA patients scheduled to undergo TKA. The aim is to establish a robust foundation for the application of the CSI in preoperative screening specifically for TKA procedures. Materials and methods The medical ethics committee of Honghui Hospital approved this prospective observational study (No. 202105010). All experiments were performed in accordance with the Declaration of Helsinki. All participants provided written informed consent. Translation and cross-cultural adaptation To culturally adapt the CSI, a translation and back-translation approach was employed [35]. Initially, the CSI was translated from English to simplified Chinese by two native Chinese speakers: an orthopedic surgeon proficient in English and a professional standard translator. The translation preserved the original English version's items and scoring instructions without any modifications. An experienced cross-cultural adaptation expert collaborated with the two translators to merge their translations into a unified version. Following that, two other English-speaking individuals with no medical background independently retranslated the preliminary unified version back into English. Back translation is an effectiveness verification process aimed at ensuring that the translated version accurately conveys the same item content as the original version. This step frequently highlights any ambiguities or unclear phrasing in the translation [36]. To further refine the simplified Chinese version of the CSI, a pretest was conducted with 50 elderly patients suffering from end-stage KOA. Their feedback was collected and considered during the reconciliation process, comparing the back-translated version with the original version. Subsequently, all researchers involved in the study deliberated upon the testing issues and developed the final version of the simplified Chinese CSI (CSI-CV). Participants Between July 2021 and December 2022, patients with end-stage KOA who were scheduled to undergo TKA were recruited from the Department of Knee Joint Surgery at Honghui Hospital in Xi'an City, Shaanxi Province, China. The inclusion criteria for this study were as follows: (a) patients older than 18 years old with end-stage KOA who were scheduled to undergo primary unilateral TKA; (b) whose cognitive level meets the requirements for completing the questionnaire; (c) who were fluent in Mandarin at a conversational level; and (d) who consented to participate. Exclusion criteria were: (a) patients with a history of other vascular, nerve, muscle, and bone diseases that affect movement or produce pain symptoms, such as hemiplegia, fractures, ligament injuries, lower extremity vascular injuries, etc.; (b) Patients who have previously undergone TKA; (c) patients with serious diseases that affect daily life, such as coronary heart disease, asthma, mental illness, etc. The self-assessment questionnaires were administered by a trained interviewer who instructed the participants to independently complete the questionnaire before TKA. After receiving the completed questionnaires, a thorough review was conducted to identify any missing items. In instances where items were found to be missing, participants were kindly requested to provide the necessary answers [37]. To ensure consistency, standardized instructions were given to participants regarding how to complete the missing items [22]. To evaluate test–retest reliability, 100 patients from the first interview were randomly selected and were asked to complete the CSI-CV again within an interval of 1 weeks, before TKA. Questionaries All patients were required to complete the questionnaires as briefly described below. Demographic information Every participant was required to fill out the general demographic information questionnaire, which included age, body mass index, gender, employment status, living situation and educational level. The CSI-CV The CSI-CV consists of two sections: Part A and Part B [19]. Part A evaluates 25 symptom items. Participants rate the frequency of each symptom using a Likert scale ranging from 0 (never) to 4 (always), resulting in a total possible score of 100. Higher scores indicate a greater self-reported symptom burden. To aid clinical interpretation, five severity levels have been recommended: subclinical (0–29), mild (30–39), moderate (40–49), severe (50–59), and extreme (60–100) [38]. Part B is not scored and focuses on assessing 10 CSS-related diagnoses. Participants are asked two questions: (1) whether they have been previously diagnosed with each of these disorders by a doctor, and (2) the year of diagnosis. The EuroQol five-dimensional questionnaire (EQ-5D) The EQ-5D is a self-administered measurement instrument used to assess health-related quality of life. It comprises five domains (mobility, self-care, functional activity, pain/discomfort, and anxiety/depression) and is measured on a five-grade scale: no difficulties, slight difficulties, moderate difficulties, severe difficulties, and extremely severe difficulties [39, 40]. The brief pain inventory (BPI) The BPI consists of two main scores: the pain severity score and the pain interference score [41]. The pain severity score is determined by four items that measure the patient's "most severe", "least severe" and "average" pain experienced in the past 24 h, as well as their current pain at the time of completing the questionnaire. Each item is rated on a scale of 0 to 10, ranging from "no pain" to "the most severe pain imaginable". The pain interference score is calculated based on seven items that evaluate the extent to which pain affects various aspects of life. Each item is rated on a scale of 0 to 10, ranging from "no interference" to "complete interference". The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) The WOMAC is divided into three domains: stiffness (two items), pain (five items), and physical function (17 items) [42]. Each item is rated on a scale of 0 to 10. The scores from the three domains are then combined to generate a total score, with higher scores indicating increased pain, stiffness, and impaired function. Sample size determination To determine the appropriate sample size, we followed the recommendations for conducting factor analysis. These recommendations suggest having 4 to 10 participants per item [43] and a total sample size of more than 100 participants [44]. Therefore, the final sample size of this study was determined to be ≥ 250 cases. Statistical analysis Descriptive statistics were used to summarize the demographic and clinical characteristics of the participants, with the mean and SD calculated for continuous variables, and percentages calculated for categorical variables. The Kolmogorov–Smirnov test was used to assess the normality of the CSI-CV, EQ-5D, WOMAC, and BPI total scores. T-tests and one-way analysis of variance (ANOVA) with Bonferroni correction were employed to compare CSI-CV scores across subjects with different characteristics. This analysis aimed to assess the discriminant validity of the scale. All statistical analyses were conducted using SPSS 24.0 (Chicago, IL). The significance level was set at 0.05. Structural validity Since the factorial structure of the CSI has been shown to vary in different language versions [20–30], structural validity of the CSI-CV was investigated with an exploratory approach to assess the number of factors. The adequacy for these analyses was calculated by the Kaiser–Meyer–Olkin test and Bartlett’s test of sphericity. An exploratory factor analysis (EFA) was conducted with the maximum likelihood method using a promax rotation. Factors were considered for eigenvalues > 1.0. The cut-off for the loadings should be set at 0.4 [45]. Criterion validity The Pearson correlation coefficient was used to test the criterion validity of the CSI-CV with the EQ-5D, WOMAC and BPI. The correlation levels were set as follows: > 0.81, very strong correlation; 0.61–0.80, strong correlation; 0.41–0.60, moderate correlation; 0.21–0.40, weak correlation; and < 0.20, none or very weak correlation [46]. Before this analysis, based on assessment of the content of the items on the scales, we hypothesized that the CSI-CV scores correlated moderately with the total scores of the EQ-5D, WOMAC and BPI. Internal consistency and test–retest reliability Internal consistency indicates how closely related a set of items is as a group, which is usually measured by Cronbach's α coefficients. The coefficient α was set as follows: < 0.70, poor or unacceptable; 0.70–0.79, fair; 0.80–0.89, good; and ≥ 0.90, excellent [47]. Test–retest reliability was assessed using the intraclass correlation coefficient (ICC), which was derived from a 2-way analysis of variance in a random effect model. ICC values between 0.5 and 0.75 indicated moderate reliability, values between 0.75 and 0.9 indicated good reliability, and values greater than 0.9 suggested excellent reliability [48]. Guttman's split-half reliability coefficients were calculated to evaluate scale reliability and equivalence [37]. It is recommended that the interval between repeated measurements should be 1–2 weeks [49]. We decided to send the questionnaire again after an interval of 7 days. Item screening Items were screened based on their factor loadings of item scores and Cronbach's α coefficient. Item deletion was contemplated if the item’s factor loading was less than 0.4, and the Cronbach's α coefficient of the entire scale increased after removing the item compared to before its removal [37]. Measurement error Standard error of measurement (SEM) is an indicator of absolute reliability [49]. The most common calculation method for this statistic is the following equation: SEM = SD·\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\sqrt{(1-R)}$$\end{document}(1-R), SD = the sample standard deviation, and R = the calculated ICC [50]. Smallest detectable change The smallest detectable change (SDC) reflects the smallest within-person change in score, calculated using the formula SDC(95% CI) = 1.96·\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\sqrt{2}$$\end{document}2·SEM [49]. Feasibility Each participant was queried about any challenges encountered while completing the questionnaire. The feasibility was assessed by considering the percentage of participants who did not respond to certain items, as well as the overall time taken to complete the questionnaire. Results Participants A total of 325 patients were included in the study. The demographic data of all the participants are shown in Table 1.Table 1Demographic data of participantsItemsParticipants (n = 325)Age (SD, range)65.6 years (6.5, 45.0 to 79.0)Body mass index (SD, range)26.1 kg/m2 (2.9, 19.0 to 32.0)GenderMale96 (29.5%)Female229 (70.5%)Employment statusIn work210 (64.6%)Be unemployed20 (6.2%)Retired95 (29.2%)Living situationLiving alone80 (24.6%)With spouse220 (67.7%)With children25 (7.7%)EducationPrimary school or below138 (42.5%)Middle school122 (37.5%)High school or above65 (20.0%)SD standard deviation Table 1Demographic data of participantsItemsParticipants (n = 325)Age (SD, range)65.6 years (6.5, 45.0 to 79.0)Body mass index (SD, range)26.1 kg/m2 (2.9, 19.0 to 32.0)GenderMale96 (29.5%)Female229 (70.5%)Employment statusIn work210 (64.6%)Be unemployed20 (6.2%)Retired95 (29.2%)Living situationLiving alone80 (24.6%)With spouse220 (67.7%)With children25 (7.7%)EducationPrimary school or below138 (42.5%)Middle school122 (37.5%)High school or above65 (20.0%)SD standard deviation Demographic data of participants SD standard deviation Cross-cultural adaptation and Item screening results The forward and backward translations of the CSI into simplified Chinese were successfully completed, as described in Additional file 1, without encountering any major issues. All item’s factor loadings were above 0.4 (Table 3). Additionally, the Cronbach's α coefficient for the scale did not increase after removing any item. Therefore, no item needed to be removed following the screening process. Prevalence The CSI scores among the 325 patients ranged from 8 to 62, with a mean of 29.6 (SD = 10.1). Of the 325 patients, 168 patients indicated subclinical, 119 patients indicated mild, and 38 patients indicated moderate or higher severity. As shown in Table 2, of the total 325 patients, 35 (10.8%) patients were diagnosed with CS-related diseases. Patients diagnosed with only one CSS (25 patients, 47.2 ± 6.9) or 2 CSSs (10 patients, 54.4 ± 4.9) scored higher on the CSI than those with no CSS diagnosis (290 patients, 27.2 ± 7.5; P < 0.01).Table 2Prevalence rates of CS severity levels and frequency of diagnosesCSI-CV scoreN (%)Subclinical (0–29)168 (51.7)Mild (30–39)119 (36.6)Moderate (40–49)18 (5.5)Severe (50–59)17 (5.2)Extreme (> 60)3 (0.9)DiagnosesRestless leg syndrome1 (0.3)Chronic fatigue syndrome2 (0.6)Fibromyalgia6 (1.8)Temporomandibular joint disorder0 (0)Migraine or tension headaches5 (1.5)Irritable bowel syndrome4 (1.2)Multiple chemical sensitivities1 (0.3)Neck injury (including whiplash)4 (1.2)Anxiety or panic attacks4 (1.2)Depression18 (5.5)CS central sensitization, CSI-CV simplified Chinese version of the Central Sensitization Inventory Table 2Prevalence rates of CS severity levels and frequency of diagnosesCSI-CV scoreN (%)Subclinical (0–29)168 (51.7)Mild (30–39)119 (36.6)Moderate (40–49)18 (5.5)Severe (50–59)17 (5.2)Extreme (> 60)3 (0.9)DiagnosesRestless leg syndrome1 (0.3)Chronic fatigue syndrome2 (0.6)Fibromyalgia6 (1.8)Temporomandibular joint disorder0 (0)Migraine or tension headaches5 (1.5)Irritable bowel syndrome4 (1.2)Multiple chemical sensitivities1 (0.3)Neck injury (including whiplash)4 (1.2)Anxiety or panic attacks4 (1.2)Depression18 (5.5)CS central sensitization, CSI-CV simplified Chinese version of the Central Sensitization Inventory Prevalence rates of CS severity levels and frequency of diagnoses CS central sensitization, CSI-CV simplified Chinese version of the Central Sensitization Inventory Structural validity The results of the Kaiser–Meyer–Olkin test (0.784) and the Bartlett’s test of sphericity (P < 0.001) confirmed that the data was suitable for factor analysis. EFA and screen plot (Fig. 1) resulted in a five-factor model. The eigenvalues of the Factor 1 to Factor 5 were 6.58, 5.62, 2.70, 2.10 and 1.83, and the variance contribution rates of the Factor 1 to Factor 5 were 26.32%, 22.49%, 10.80%, 8.38% and 7.30%, respectively. The cumulative variance contribution rate was 75.3%. The factors matrix is presented in Table 3. Items 3, 5, 6, 13, 15, 16, 23 and 24 were loaded on factor 1, which was named “Emotional Distress”. Factor 2 consisted of items 4, 7, 10 and 19, and was named “Headache and Jaw Symptoms”. Factor 3 consisted of items 2, 9, 14, 17, 18 and 20, and was named “Physical Symptoms”. Factor 4 consisted of items 11, 21 and 25, and was named “Urological Symptoms”. Factor 5, consisting of items 1, 8, 12, and 22, exhibited a significant association with fatigue and sleep-related difficulties. Consequently, we appropriately labeled this factor as "Fatigue and Sleep Problems".Fig. 1Scree plot of exploratory factor analysisTable 3Factor loadings of the EFA with promax rotationItem no.QuestionF1F2F3F4F5Original version [19]Hongkong version [23]5Diarrhea/constipation0.939F3Not loading16Sad or depressed0.938F1F16Need help with daily activity0.935F3Not loading15Stress makes symptoms worse0.930F1Not loading13Difficulty concentrating0.929F1F13Anxiety attacks0.908F1F124Trauma as a child0.768F1Bladder and teeth grinding disorders23Poor memory0.697F1Concentration and memory problem19Pain in jaw0.955F2Not loading7Sensitive to bright lights0.927F2Hypersensitivity syndrome4Grind/clench teeth0.922F2Bladder & teeth grinding disorders10Headaches0.896F2Not loading17Low energy0.854F3Concentration and memory problem2Muscles stiff/achy0.769F3F314Skin problems0.709F3Not loading20Certain smells make dizzy0.676F2Not loading9Pain all over body0.591F3F318Tension neck and shoulder0.512F3F311Bladder/urination pain0.907F4Bladder & teeth grinding disorders25Pelvic pain0.896F4Not loading21Urinate frequently0.822F4Hypersensitivity syndrome22Restless legs0.857F3Not loading12Do not sleep well0.807F3Not loading8Easily tired with physical activity0.741F3F31Unrefreshed in morning0.565F3Not loadingEFA exploratory factor analysis, F1 Emotional Distress, F2 Headache and Jaw Symptoms, F3 Physical Symptoms, F4 Urological Symptoms, F5 Fatigue and Sleep Problems Scree plot of exploratory factor analysis Table 3Factor loadings of the EFA with promax rotationItem no.QuestionF1F2F3F4F5Original version [19]Hongkong version [23]5Diarrhea/constipation0.939F3Not loading16Sad or depressed0.938F1F16Need help with daily activity0.935F3Not loading15Stress makes symptoms worse0.930F1Not loading13Difficulty concentrating0.929F1F13Anxiety attacks0.908F1F124Trauma as a child0.768F1Bladder and teeth grinding disorders23Poor memory0.697F1Concentration and memory problem19Pain in jaw0.955F2Not loading7Sensitive to bright lights0.927F2Hypersensitivity syndrome4Grind/clench teeth0.922F2Bladder & teeth grinding disorders10Headaches0.896F2Not loading17Low energy0.854F3Concentration and memory problem2Muscles stiff/achy0.769F3F314Skin problems0.709F3Not loading20Certain smells make dizzy0.676F2Not loading9Pain all over body0.591F3F318Tension neck and shoulder0.512F3F311Bladder/urination pain0.907F4Bladder & teeth grinding disorders25Pelvic pain0.896F4Not loading21Urinate frequently0.822F4Hypersensitivity syndrome22Restless legs0.857F3Not loading12Do not sleep well0.807F3Not loading8Easily tired with physical activity0.741F3F31Unrefreshed in morning0.565F3Not loadingEFA exploratory factor analysis, F1 Emotional Distress, F2 Headache and Jaw Symptoms, F3 Physical Symptoms, F4 Urological Symptoms, F5 Fatigue and Sleep Problems Factor loadings of the EFA with promax rotation EFA exploratory factor analysis, F1 Emotional Distress, F2 Headache and Jaw Symptoms, F3 Physical Symptoms, F4 Urological Symptoms, F5 Fatigue and Sleep Problems Criterion validity The correlations between the CSI-CV and EQ-5D, BPI and WOMAC were showed in Table 4. As hypothesized, the results revealed positive correlations between CSI-CV scores and the scores of EQ-5D, BPI, and WOMAC.Table 4Results of bivariate correlations between CSI-CV and related scalesVarianceMean (SD)Correlation coefficientP-valueHealth-related QOL (EQ-5D)13.1 (3.6)0.576 < 0.001BPI43.4 (17.0)0.506 < 0.001WOMAC91.5 (39.1)0.466 < 0.001SD standard deviation Table 4Results of bivariate correlations between CSI-CV and related scalesVarianceMean (SD)Correlation coefficientP-valueHealth-related QOL (EQ-5D)13.1 (3.6)0.576 < 0.001BPI43.4 (17.0)0.506 < 0.001WOMAC91.5 (39.1)0.466 < 0.001SD standard deviation Results of bivariate correlations between CSI-CV and related scales SD standard deviation Internal consistency and test–retest reliability The CSI-CV exhibited a strong level of internal consistency (Cronbach’s α = 0.83), with individual factor scores ranging from 0.76 to 0.98. Furthermore, the Guttman split-half reliability coefficient was determined to be 0.88, with individual factor scores ranging from 0.59 to 0.92. These findings indicate that each item within the measure showed significant correlation with the overall factor being assessed. Test–retest reliability was excellent with an ICC of 0.965. All factors of the CSI had an excellent ICC greater than 0.90. The SEM was 1.89 points (Table 5).Table 5Cronbach’s α, intraclass correlation coefficients, and Guttman split-half coefficient of test–retest reliabilityItem no.QuestionsCronbach’s αICCGuttman split-half coefficientSumTotal score0.830.9650.88Factor 1Emotional Distress0.960.9650.92Factor 2Headache and Jaw Symptoms0.980.9480.98Factor 3Physical Symptoms0.790.9100.79Factor 4Urological Symptoms0.860.9710.78Factor 5Fatigue and Sleep Problems0.760.9660.71ICC intraclass correlation coefficients Table 5Cronbach’s α, intraclass correlation coefficients, and Guttman split-half coefficient of test–retest reliabilityItem no.QuestionsCronbach’s αICCGuttman split-half coefficientSumTotal score0.830.9650.88Factor 1Emotional Distress0.960.9650.92Factor 2Headache and Jaw Symptoms0.980.9480.98Factor 3Physical Symptoms0.790.9100.79Factor 4Urological Symptoms0.860.9710.78Factor 5Fatigue and Sleep Problems0.760.9660.71ICC intraclass correlation coefficients Cronbach’s α, intraclass correlation coefficients, and Guttman split-half coefficient of test–retest reliability ICC intraclass correlation coefficients SDC The SDC, representing the smallest change of value for a scale that could be considered an actual change rather than measurement of error, was 5.22 points. Feasibility All participants completed Part A of the CSI-CV without any difficulties, and there were no issues with missing or multiple answers. However, it is worth noting that some patients experienced difficulties in completing Part B. These challenges were attributed to their limited familiarity with certain diagnoses. The average time for completing the questionnaires was 6.4 ± 1.3 min. Discriminant validity There was no significant difference in CSI scores between two groups of patients of different ages. The total scores of the CSI-CV differed significantly according to gender, employment status, living situation and education. The results indicated that women scored significantly higher than men on the CSI-CV scale. Additionally, unemployed individuals obtained significantly higher scores compared to working individuals and retirees. Furthermore, individuals living alone achieved significantly higher scores than those living with their spouse or children. Lastly, individuals with lower education levels obtained significantly higher scores compared to those with higher education levels (Table 6).Table 6CSI-CV scores in different populationsFactorNTotal score of CSIP valueAge ≥ 70 years old12130.0 ± 9.40.545 < 70 years old20430.5 ± 10.5GenderMale9627.5 ± 8.1a0.018Famale22930.4 ± 10.8aEmployment statusIn work21030.2 ± 9.1a < 0.001Be unemployed2043.4 ± 10.7aRetired9525.3 ± 9.3aLiving situationLiving alone8031.6 ± 11.1a0.035With spouse22029.2 ± 9.9With children2526.0 ± 7.3aEducationPrimary school or below13831.9 ± 10.1a0.001Middle school12227.5 ± 10.3aHigh school or above6528.4 ± 9.0Values are expressed as means ± standard deviation. a Items with significant differences. P value represents the comparison result of T-tests or ANOVA with Bonferroni correction Table 6CSI-CV scores in different populationsFactorNTotal score of CSIP valueAge ≥ 70 years old12130.0 ± 9.40.545 < 70 years old20430.5 ± 10.5GenderMale9627.5 ± 8.1a0.018Famale22930.4 ± 10.8aEmployment statusIn work21030.2 ± 9.1a < 0.001Be unemployed2043.4 ± 10.7aRetired9525.3 ± 9.3aLiving situationLiving alone8031.6 ± 11.1a0.035With spouse22029.2 ± 9.9With children2526.0 ± 7.3aEducationPrimary school or below13831.9 ± 10.1a0.001Middle school12227.5 ± 10.3aHigh school or above6528.4 ± 9.0Values are expressed as means ± standard deviation. a Items with significant differences. P value represents the comparison result of T-tests or ANOVA with Bonferroni correction CSI-CV scores in different populations Values are expressed as means ± standard deviation. a Items with significant differences. P value represents the comparison result of T-tests or ANOVA with Bonferroni correction Discussion The objective of this study was to develop a culturally adapted simplified Chinese version of the CSI and assess its psychometric properties among patients undergoing TKA for KOA. Among these patients, there is considerable variation in the presence and intensity of CS. Previous research has shown that CS predicts poor treatment outcomes in TKA patients [6–10]. This emphasizes the critical importance of individualized assessments to precisely evaluate each patient's condition [51]. Such screening can provide valuable information that enables early intervention [13] before or intensive treatment after TKA. Furthermore, by identifying CS in KOA patients before surgery, surgeons can engage in shared decision-making with patients, discussing the potential implications of CS on their postoperative recovery and setting realistic expectations [5, 52, 53]. In our study, EFA revealed a 5-factor model for the CSI-CV, which aligns with the findings from the Japanese [20] and French [31] versions. However, the English version demonstrated a 4-factor model [19], the Spanish version showed a 1-factor model [27], and the Korean version resulted in a 6-factor model [30]. Table 3 displays the factor loading of each item across different versions of the CSI. The observed variations in the factor structure between this study and previous studies conducted with other language versions [19, 27, 30] underscore the influence of cultural and linguistic factors on the conceptualization of CS in different populations [20, 30]. These findings emphasize the importance of adapting assessment tools to specific cultural settings to ensure their validity and reliability in measuring the construct of interest [20]. The ICC indicated that the CSI-CV has excellent reliability, at 0.965. The results corroborated earlier reports on English (0.817) [19], Japanese (0.85) [20], Korean (0.941) [30], French (0.91) [31] and Brazilian (0.91) [32] versions. In addition, the CSI-CV demonstrated good criterion validity when compared to the BPI, the WOMAC, and the EQ-5D. The level of correlation observed was similar to that of the Korean and Japanese versions of the CSI [20, 30]. All of these findings collectively support the strong psychometric properties of the CSI-CV. The CSI-CV exhibited a high level of internal consistency with a Cronbach's alpha of 0.83. Additionally, the 25 sub-items displayed high Cronbach's α values ranging from 0.82 to 0.83. These values were consistent with the English (0.87) [19], Japanese (0.89) [20], Korean (0.94) [30], Spanish (0.87) [27], and Italian (0.87) [29] versions. This indicates that the CSI remains stable internal consistency across different cultural contexts. Only a few of the initial validation studies [22, 25, 26] computed the SEM and the SDC. The SEM values ranged from 0.31 [25] to 4.14 [22], while the SDC values ranged from 0.86 [25] to 11.48 [22]. In this study, the values for SEM and SDC are 1.89 and 5.22, respectively, falling between the two ranges mentioned. The differences in these values could be attributed to specific factors. In the Nepali study [25], participants were provided with baseline measurement values during the follow-up, and the CSI was administered face-to-face. These factors may have influenced participant responses and introduced potential biases. Conversely, the longer interval between measurements in the German study [22] could have minimized memory effects, potentially increasing the values of SEM and SDC. Based on the current findings, any change score greater than 5.2 units (out of 100) may be considered a true change for the CSI-CV. In addition to its psychometric properties, the feasibility of the CSI-CV was also evaluated in this study. The time required to complete the CSI-CV was found to be relatively short, with participants spending an average of 6.4 ± 1.3 min to complete the questionnaire. The brevity of the CSI-CV allows for efficient administration, reducing participant burden and increasing the likelihood of compliance. The CSI scores in the present study ranged from 8 to 62, with a mean of 29.6 ± 10.1. These scores were lower than those reported in Germany (43.6 ± 15.0) [22], Korea (33.4 ± 15.7) [30], Serbia (38.3 ± 15.7) [26], Italy (35.3 ± 14.6) [29], Brazil (45.4 ± 17.4) [32], and Hong Kong of China (36.4 ± 13.1) [23]. On the other hand, the scores in this study were higher compared to the Japan [20] and Nepal [25] studies. In addition, in the present study, the proportion of CSS diagnoses was found to be 10.8%, which is lower than the proportions reported in most studies conducted in other areas ranging from 13 [23] to 56% [29]. These variations in CSI scores and the prevalence of CSS diagnoses can be attributed to various factors, such as cultural, racial, and medical differences among the patient populations [51]. Cultural and societal attitudes towards mental health can influence patients' willingness to acknowledge and disclose their own mental sensitivities. In this study, the patients were recruited from underdeveloped inland areas in northwest China, where a relatively conservative social atmosphere may discourage individuals from openly admitting their mental health issues. Additionally, limited access to advanced medical resources has led to underdiagnosis of CSS in many patients. These disparities underscore the importance of exercising caution when interpreting scale scores in diverse cultural contexts, and suggest that the clinical threshold for identifying CS may need to be adjusted to accommodate the unique social environment in China [23]. Furthermore, it is important to note that the present study focused specifically on patients undergoing TKA due to KOA. This distinguishes it from previous studies that included a broader range of conditions such as musculoskeletal pain, fibromyalgia, and acute injury pain [20–30]. The specific patient population targeted in this study may have contributed to the observed differences in CSI-CV scores. The CSI total score exhibits a substantial disparity among individuals with different demographic characteristics. Specifically, women tend to have significantly higher CSI scores compared to men, aligning with previous research findings indicating that women with acute pain are more likely to experience persisting pain [51, 54]. Furthermore, unemployed individuals, those living alone, and those with lower education levels also display higher CSI scores, likely due to the increased economic and social pressures they face. Consequently, it is imperative that healthcare professionals prioritize these specific groups and offer proactive measures, such as early interventions like Duloxetine [13, 55, 56] or Pregabalin [57–59] during the perioperative period. Numerous limitations of the present study should be acknowledged. Firstly, all participants were recruited from a single hospital, predominantly representing patients in northwestern China. Given the vast land area of China, the generalizability of the findings to other regions of mainland China may be limited. Secondly, the assessment of CSS was based on self-report questionnaires, which introduces the potential for response bias. Thirdly, we did not directly measure CS using QST in our study. Further research is required to investigate the validation of the CSI-CV, which could involve incorporating QST as a complementary measure. Lastly, the study did not include healthy individuals, warranting future research to investigate whether the CSI-CV can effectively differentiate individuals with and without CS. Conclusions In conclusion, the linguistic translation and cultural adaptation of the CSI from the original English version to simplified Chinese were successfully completed, ensuring the equivalence of all items. The CSI-CV demonstrated strong psychometric properties, including reliability, validity, and ease of understanding. These findings provide robust evidence supporting the use of the CSI-CV as a reliable instrument for screening CS in Chinese-speaking patients with KOA prior to undergoing TKA. Supplementary Information Additional file 1. Simplified Chinese version of the Central Sensitization Inventory. Additional file 1. Simplified Chinese version of the Central Sensitization Inventory.